Use on Tallman drug names

Home Forums General Discussions Use on Tallman drug names

Viewing 4 posts - 1 through 4 (of 4 total)
  • Author
  • #993
    Ian Barnard

    Has anyone either investigated or implemented using Tallman lettering for similar drug names? I demonstrated this to some of our clinicians as part of an overview of the possibilities of ePMA and they quite liked the idea and was wondering whether anyone had any thoughts or evidence of benefits.

    Many thanks

    eP team

    The benefits have not been proven and gathering evidence remains difficult – the work to date however suggests that it makes people stop and think a little longer. The use of this approach therefore remains at one’s “own risk” and if using it, it is important to ensure that the organisation understands what it stands for. There are some suggestions that capitalising the middle of the name may be the best option, as explained in this article which also includes references to other research carried out in this area.

    Dan Hibell

    Hi all,

    My trust are in the process of “rolling-out” EPMA and I recently found this NPSA document on Tall-Man lettering and other issues regarding on-screen display of medication information.

    Hope it helps,



    Freeware gay porn
    gay rainbow gay halloween costumes free online gay chat marvin gaye biography gay cam

Viewing 4 posts - 1 through 4 (of 4 total)
  • You must be logged in to reply to this topic.
NIHR Programme Grant for Applied Research, Principal Investigator: Professor Aziz Sheikh
Collaborators' logos The University of Edinburgh Harvard University The University of Nottingham University of Birmingham University Hospitals Birmingham
Developed by the Interactive Content Team, Information Services. Copyright © 2020 The University of Edinburgh.
All rights reserved. Privacy Policy. Page last modified: July 9th, 2014.